ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,745.37
0.40%
US Tech 100
19,543.60
-0.18%
다우존스 지수
42,175.11
0.62%
Bitcoin
65,597.27
0.64%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) 뉴스

DYN

Dyne Therapeutics (DYN)

Dyne Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:DYN
일자시간출처헤드라인심볼기업
2024/09/2505:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/2321:56GlobeNewswire Inc.Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines ConferenceNASDAQ:DYNDyne Therapeutics Inc
2024/09/2105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/2005:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1905:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1905:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1905:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1205:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1205:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1205:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1205:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/1005:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/0605:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/0505:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/0407:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/0407:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/09/0320:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
2024/09/0319:31GlobeNewswire Inc.Dyne Therapeutics Announces Key Leadership AppointmentsNASDAQ:DYNDyne Therapeutics Inc
2024/09/0319:30GlobeNewswire Inc.Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple CohortsNASDAQ:DYNDyne Therapeutics Inc
2024/08/3105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2920:30GlobeNewswire Inc.Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:DYNDyne Therapeutics Inc
2024/08/2905:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2705:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2305:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2205:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2105:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2105:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2105:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
2024/08/2005:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
 검색 관련기사 보기:NASDAQ:DYN

최근 히스토리

NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
FX
USDEUR
US Dollar vs Euro
NYSE
BAC
Bank of America
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유